New Delhi, October 9: The Supreme Court on Thursday agreed to hear on October 10 a PIL seeking CBI investigation into the death of children in Madhya Pradesh and Rajasthan after consumption of toxic cough syrup. A bench headed by Chief Justice of India BR Gavai said it would post the matter for hearing on Friday, after advocate Vishal Tiwari mentioned it for urgent hearing.

The PIL filed sought a retired Supreme Court judge to monitor a probe and inquiry into the manufacture, regulation, testing and distribution of contaminated cough syrups. The petition filed by advocate Tiwari called for the constitution of a National Judicial Commission or Expert Committee headed by a retired Supreme Court judge to conduct a comprehensive inquiry into the manufacture, testing, and distribution of contaminated cough syrups containing Diethylene Glycol (DEG) and Ethylene Glycol (EG), the same toxic compounds that have previously caused fatalities. Cough Syrup Deaths: DCGI Tells States and UTs To Take Measures To Ensure Testing of Cough Syrups Before Manufacture and Release of Batch to the Market.

It sought direction from the Centre to set up a National Judicial Commission or Expert Committee to investigate the regulatory failures that allowed the circulation of substandard cough syrups, and to suggest robust measures to prevent such tragedies. The proposed body should be chaired by a retired Supreme Court judge and include experts in pharmacology, toxicology, and drug regulation, it suggested.

The PIL also sought a direction to transfer all pending FIRs and investigations related to the child deaths due to poisonous cough syrups in various states to the Central Bureau of Investigation (CBI), under the supervision of a former Supreme Court judge, to ensure an impartial, coordinated probe. Multiple state-level inquiries have resulted in fragmented accountability, allowing recurring instances of toxic formulations to reach consumers, it added. Cough-Syrup Related Deaths: Tamil Nadu Halts Production of Coldrif Syrup After Child Deaths in MP and Rajasthan.

As per the reports, several children died in Madhya Pradesh and Rajasthan after consuming Coldrif Cough Syrup, a formulation manufactured by M/s Sresan Pharma Pvt. Ltd., a Tamil Nadu-based pharmaceutical company. The petition called for "immediately recall, seize and prohibit the sale and distribution of all batches of Coldrif Cough Syrup and any other formulations manufactured by M/s Sresan Pharma Pvt. Ltd., Tamil Nadu, or any related companies, pending toxicological clearance and verification of safety standards by independent NABL-accredited laboratories."

It further sought direction to the Centre to conduct nationwide mandatory testing of all syrup-based pharmaceutical formulations for the presence of Diethylene Glycol (DEG) and Ethylene Glycol (EG), and to publish the results of such testing in the public domain for transparency and public safety. The petition sought direction to suspend or cancel the manufacturing licenses of pharmaceutical companies found involved in the production or distribution of contaminated medicines, and to initiate criminal prosecution against those responsible for the loss of human life.

(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)

TruLY Score by LatestLY
Rating:4

TruLY Score 4 – Reliable | On a Trust Scale of 0-5 this article has scored 4 on LatestLY. The information comes from reputable news agencies like (ANI). While not an official source, it meets professional journalism standards and can be confidently shared with your friends and family, though some updates may follow.